What is Insulin degludec?

Category: Prescription Drugs

Most popular types: Tresiba

false

Insulin degludec is a formulation of basal insulin that is considered to be ultra-long acting. 

Side effects

Side effects as an overall problem

Side effects as an overall problem
Severity Evaluations
Severe
0
Moderate
0
Mild
0
None
2

Commonly reported side effects and conditions associated with Insulin degludec

Side effect Patients

Dosages

Based on patients currently taking Insulin degludec

Dosage Patients
100 units daily 2
4,000 units daily 2
100 units weekly 1
25 other daily 1
30 mg twice daily 1
75 intl units daily 1
1,100 units daily 1
2,200 units daily 1

Why patients stopped taking Insulin degludec

Multiple reasons could be selected

Reason Patients
Other 1
See 1 patient who's stopped taking Insulin degludec

Duration

Currently taking Insulin degludec

Duration Patients
1 - 6 months 2
6 months - 1 year 3
1 - 2 years 5

Stopped taking Insulin degludec

Duration Patients
1 - 6 months 1
Adherence
Adherence Evaluations
Always 2
Usually 0
Sometimes 0
Never taken as prescribed 0
Burden
Burden Evaluations
Very hard to take 1
Somewhat hard to take 0
A little hard to take 0
Not at all hard to take 1
Cost per month
Cost per month Evaluations
$200+ 0
$100-199 0
$50-99 0
$25-49 0
< $25 1
Not specified 1

What people switch to and from

Patients started taking Insulin degludec after stopping:

Treatment Patients
Insulin Glargine (Lantus) 6
insulin detemir (Levemir FlexPen) 2
Insulin Lispro (Humalog) 1
Insulin NPH (Novolin N) 1

Patients stopped taking Insulin degludec and switched to:

Treatment Patients
insulin detemir (Levemir FlexPen) 1
Last updated:
There are no evaluations for Insulin degludec.